https://majorhealthnews.com/press-releases/novo-real-world-studies-link-wegovyr-24-mg-to-reductions-in-liver-enzymes-weight-andMajor Health Newsen2026-11-06T20:21:53.672ZNovo real-world studies link Wegovy® 2.4 mg to reductions in liver enzymes, weight, and blood sugar in adults with MASH at The Liver Meeting® (AASLD) 2026 https://majorhealthnews.com/press-releases/zydus-therapeutics-presents-phase-2b-data-at-aasld-2026-showing-greater-resolution-ofMajor Health Newsen2026-11-06T16:38:04.064ZZydus Therapeutics Presents Phase 2b Data at AASLD 2026 Showing Greater Resolution of Steatohepatitis Without Worsening of Fibrosis With Investigational Saroglitazar Compared to Placebo in Adults With MASH and Fibrosis https://majorhealthnews.com/press-releases/halozyme-reaffirms-it-projects-zero-to-minimal-impact-to-royalty-revenue-through-at-leastMajor Health Newsen2026-11-06T15:16:45.619ZHalozyme Reaffirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Medicare Drug Price Negotiation Program Final Rule for IPAY 2029 https://majorhealthnews.com/press-releases/insilico-open-sources-247-personal-longevity-superintelligence-to-turn-quantified-selfMajor Health Newsen2026-11-06T14:14:10.752ZInsilico Open-Sources 24/7 Personal Longevity Superintelligence to Turn Quantified-Self Data into Predictive Health States and Aging Research https://majorhealthnews.com/press-releases/servier-highlights-growing-neuro-oncology-portfolio-with-new-data-across-pediatric-andMajor Health Newsen2026-11-06T13:17:11.655ZServier Highlights Growing Neuro-Oncology Portfolio with New Data Across Pediatric and Adult Glioma at SNO 2026 https://majorhealthnews.com/press-releases/aligos-therapeutics-reports-recent-business-progress-and-third-quarter-2026-financialMajor Health Newsen2026-11-06T13:06:49.036ZAligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results